Join Sarah Hunter, PhD; Lori Uscher-Pines, PhD; Lawrence Brown, MD, MPH, FACP, DFASAM; Lisa Brown, DNP, PMHNP-BC, FNP-NC; Mark Parrino, MPA; and Betty Tai, PhD, as they discuss findings, experiences, and provide commentary on how the COVID-19 pandemic has altered the delivery of methadone treatment in the United States.
Join Helena Hansen, MD, PhD, Hansel Tookes, MD, MPH, Morgan Medlock, MD, MDiv, MPH, and H. Westley Clark, MD, JD, MPH, as they discuss racial and ethnic disparities in accessing evidence-based OUD treatment, the impact of the COVID-19 pandemic, and potential solutions towards a more equitable system of care.
Read about how the COVID-19 pandemic presents learning opportunities to FORE to expand access to opioid use disorder treatment in an article authored by FORE President, Dr. Karen A. Scott.
Join Julia Felton, PhD, Jessica Magidson, PhD, Karen Fortuna, MSW, PhD, Sadie M. Smith, MSW, Dwayne Dean, ICPR, CPRS, RPS, and Kristen Senters-Young, MA, as they discuss how peer recovery coaches and navigators can effectively and safely help patients sustain their recovery, as well as care for themselves, during the pandemic.
Join Shuchin Shukla, MD, MPH, Blake Fagan, MD, Vaty Poitevien, MD, and Sue Lin, PhD, MS, as they discuss the challenges and concerns that community health centers are facing while tackling both the opioid and COVID-19 public health emergencies.
Read about specific strategies that the federal government, states, and other stakeholders can use to mitigate the impact of COVID-19 on people with OUD in an article co-authored by FORE President, Dr. Karen A. Scott.